首页|miR-155/GATA3/CD4+T细胞通路对变应性鼻炎发病机制的调控

miR-155/GATA3/CD4+T细胞通路对变应性鼻炎发病机制的调控

扫码查看
变应性鼻炎(AR)指具有特异性体质的个体第二次接触相同致敏原后立即触发由免疫球蛋白E介导的Ⅰ型变态反应,其发病机制尚未明确,与多种基因、免疫细胞、细胞因子等密切相关.随着分子生物学和第二代基因测序技术快速发展,AR发病机制研究逐步深化、精准.研究发现miR-155和转录因子GATA3对AR发生发展有重要调控作用,进而影响CD4+T淋巴细胞的优势分化趋势和ILC2增生.本文主要以miR-155/GATA3通路为中心,探讨相关上游基因和下游调控物质对AR发病机制的影响并进行综述.
miR-155/GATA3/CD4+T cell pathway regulates pathogenesis of allergic rhinitis
Allergic rhinitis(AR)is a type Ⅰ allergic reaction,which mediated by immunoglobulin E immediately when an individual with a special constitution is exposed to a same allergen for second time,whose pathogenesis has not been clarified yet,and closely related to genes,immune cells and cytokines.Pathogenesis of AR become more deeper and more accurate due to rapid develop-ment of molecular biology and second-generation gene sequencing technology.Current studies have found that miR-155 and transcrip-tion factor GATA3 have important regulatory effects on occurrence and development of AR,then affect dominant differentiation of CD4+T lymphocytes and proliferation of ILC2.This article discusses and reviews pathogenesis of AR,which mainly focuses on miR-155/GATA3 pathway and effects of related upstream genes and downstream regulatory substances.

Allergic rhinitismiR-155GATA3CD4+T cellILC2

李荣荣、瞿申红、张少杰、黄雪颖、钟自玲

展开 >

右江民族医学院,百色 533000

广西壮族自治区人民医院耳鼻咽喉头颈科,南宁 530021

榆林市星元医院,榆林 719000

变应性鼻炎 miR-155 GATA3 CD4+T细胞 ILC2

国家自然科学基金地区科学基金

81960186

2024

中国免疫学杂志
中国免疫学会,吉林省医学期刊社

中国免疫学杂志

CSTPCD北大核心
影响因子:0.926
ISSN:1000-484X
年,卷(期):2024.40(3)
  • 64